Stryker (SYK) Non Operating Income (2009 - 2026)
Stryker's (SYK) quarterly Non Operating Income came in at $46.0 million in Q2 2026, down 25.81% year-over-year from $62.0 million in Q2 2025, and down 25.81% quarter-over-quarter from $62.0 million in Q1 2026.
Analysis
Stryker (SYK) Non Operating Income (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Non Operating Income for 18 consecutive years, with $46.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Income fell 25.81% year-over-year to $46.0 million in Q2 2026; TTM through Jun 2026 was $510.0 million, a 15.91% increase from a year earlier, with the FY2025 full-year figure at $232.0 million, up 9.43% from the prior year.
- Non Operating Income was $46.0 million for Q2 2026 at Stryker, down from $62.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $508.0 million in Q4 2025 and troughed at -$106.0 million in Q3 2025.
- A 5-year average of $46.6 million and a median of -$45.5 million in 2024 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 726.42% in 2023, down 875.0% in 2023.
- Over 5 years, Non Operating Income stood at -$53.0 million in 2022, then soared by 726.42% to $332.0 million in 2023, then grew by 7.23% to $356.0 million in 2024, then surged by 42.7% to $508.0 million in 2025, then slumped by 90.94% to $46.0 million in 2026.
- The last three Non Operating Income figures came in at $46.0 million (Q2 2026), $62.0 million (Q1 2026), and $508.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.42 Bn | 178.82 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.16 Bn | 118.94 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.45 Bn | 100.98 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 66.47 Bn | 65.93 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.46 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.95 Bn | 32.50 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Zimmer Biomet Holdings | 18.17 Bn | 17.76 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 508.00 Mn |
| Sep 30, 2025 | -106.00 Mn |
| Jun 30, 2025 | 62.00 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 356.00 Mn |
| Sep 30, 2024 | -42.00 Mn |
| Jun 30, 2024 | -53.00 Mn |
| Mar 31, 2024 | -49.00 Mn |
| Dec 31, 2023 | 332.00 Mn |
| Sep 30, 2023 | -62.00 Mn |
| Jun 30, 2023 | -66.00 Mn |
| Mar 31, 2023 | -56.00 Mn |
| Dec 31, 2022 | -53.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | -52.00 Mn |
| Mar 31, 2022 | -61.00 Mn |
| Dec 31, 2021 | -62.00 Mn |
| Sep 30, 2021 | -79.00 Mn |